2-(1H-1,2,3-TRIAZOL-1-YL)BENZOIC ACID, 95.0%, 100mg

(R)-3-Hydroxypiperidine hydrochloride, 98.0%, 500g

N-(4-HYDROXYPHENYL)-N,2-DIMETHYLPROPANAMIDE, 95.0%, 100mg

L-Lysine monohydrate, 100 g

1-(Pyridin-4-ylmethyl)-1H-pyrazol-4-amine, 95.0%, 100mg

3-Amino-5-methoxyphenol, 97%, 10g

tert-Butyl (4-((3-bromobenzyl)amino)-4-oxobutyl)carbamate, 97.0%, 25g

2-Methyl-2-propanyl(1R,8S)-4-nitro-11-azatricyclo[6.2.1.02,7]undeca-2,4,6-triene-11-carboxylate, 98%, 100mg

C8 alkyne dUTP, min. 95%, 100 mM in water, 50 µl, plastic packaging.

1-(Chloromethyl)-4-vinylbenzene, 500 ppm t-Butylcatechol inhibitor, 90.0%, 1g

3-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)butanenitrile, 97%, 1g

4-(3,5-dichlorobenzoyl)-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

2,5-Difluorobenzoic acid, 98.0%, 100g